Maharashtra's plan to buy drug from Bangladesh irks local companies

Indian firms said that the Bangladeshi company with which Mantralaya is in talks has neither the import licence, nor a manufacturing licence from Gilead to sell the drug in India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2BAw6if
via IFTTT